IMU

5.56%

5.7¢ imugene limited

I didn't invest because of HER-Vaxx which is why I'm asking you...

First 24950 Last

Share
Profile

Follow
AlCp

26,687 Posts.

1732

24/06/24

20:37

Post #: 74467713
Share

Originally posted by hotdogrob ↑

Maybe..but take yourself out of your own bubble Alcp and broaden your thinking..

Right about now it's more about survival and azercell for now has certainly complemented that..

The issue for Imugenes now is due to what it took to get hervax to where it is now and how that is reflected in the massive SOI..

Let's not forget the fantastic post..and I mean that... from unbelievable to start off what has been for years a great thread enjoyed by many..Go back and read that post Alcp and ask yourself what went wrong considering the data read outs..Imugenes fail to commercialize..fail fail fail..

Hervax not earning one penny now poses a problem for LT holders that being the ability to raise for ip thats no where near as advanced as hervax was..we all know trials are very very expensive..

this is not a problem for Hopper..he has cashed out to an extent and with the millions of free shares he has been given he may not even flinch at a consolidation process to reset the parameters that could rape retail once again..

I'm most certainly not concluding imu is a lifestyle company with no hope rather it's been a lifestyle company for hopper but still has hope as the trials seem to be moving along ok..

Retail need to understand on a commercial base where imu stands at this point..

hervax didnt garner any coin should be viewed as a failure and come voting season management dont deserve any retail love..no pay rises..no free shares..we paid them in advance last season and they have not produced..

don't give me trials are looking good this time..they had their chance..the score board is the MC and Lesile as CEO gets a big oi fat E on her report card no matter how nice a person she is..

hopper need to go..look at the investors he brings to the table as that as well is a reflection on Imugenes massive SOI and all the problems that is going to create in the future..

I realise the past is the past however retail needs to look at the position the past has place imugene in as we head into the future and when voting the past must be considered because it will have an impact on the future..

dyor..just my opinion and never advice

Expand

I didn't invest because of HER-Vaxx which is why I'm asking you since you are the one who is implying that PH blocked a buy out or commercial deal for HER-Vaxx. Like I previously said, BP don't care about the amount of O/S, I don't know why you continue to bring this up. Are you a ST holder???? And as I've stated previously, PH want to sell everything so he need to bring all IP to a development stage that will make BP buy everything.

Last edited by AlCp: Monday, 20:39

IMU Price at posting: 5.5¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

RCE

Recce's R327 found effective against E.coli during clinical trial

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

3DP

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

There are more pages in this discussion • 91 more messages in this thread...

First 24950 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.7¢		Change 0.003(5.56%)		Mkt cap ! $417.2M

Open	High	Low	Value	Volume
5.5¢	5.8¢	5.2¢	$2.499M	45.00M

Buyers (Bids)

No.	Vol.	Price($)
2	1921794	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	1368288	7

View Market Depth

No.	Vol.	Price($)
2	1921794	0.056
5	286362	0.055
12	3517552	0.054
17	2756044	0.053
23	2021898	0.052

Price($)	Vol.	No.
0.057	1368288	7
0.058	2564048	15
0.059	3137099	10
0.060	2176188	16
0.061	1460386	7

Last trade - 16.10pm 28/06/2024 (20 minute delay)

IMU (ASX) Chart

I didn't invest because of HER-Vaxx which is why I'm asking you...

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I didn't invest because of HER-Vaxx which is why I'm asking you...

Top Stories

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News